跳至主要内容
临床试验/NCT01945450
NCT01945450Unknown不适用

Prophylactic Antibiotics for Manual Removal of Retained Placenta in Vaginal Birth

Hadassah Medical Organization1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2014年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
300
试验地点
1
主要终点
Endometritis rate

研究概览

简要总结

Background: There is scarce evidence regarding the necessity of antibiotic prophylaxis in manual revision of the uterus after labor in cases of residual placenta.

Methods: a randomized control trial in which parturients for which the placenta was not separated or there is a suspected residual placenta will be divided randomly to two groups: (1) Revision of uterus or Manual lysis without antibiotic prophylaxis; (2) Revision of uterus or Manual lysis with antibiotic prophylaxis as following: 24 hours coverage with Ampicillin 2 grams*4, Gentamycin 240 mg*1, Clindamycin 600 mg*3. In cases of allergy to Penicillin the antibiotic regimen will be: Gentamycin 240 mg*1, Clindamycin 600 mg*3.

Outcomes: Puerperal fever, endometritis, length of hospitalization after labor, recurrent hospitalization in the first 2 weeks after discharge.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
15 Years 至 50 Years(Child, Adult)
性别
Female
接受健康志愿者

入选标准

  • suspected retained placenta

排除标准

  • Intrapartum fever

研究组 & 干预措施

Antibiotic prophylaxis

Active Comparator

antibiotic prophylaxis as following: 24 hours coverage with Ampicillin 2 grams*4, Gentamycin 240 mg*1, Clindamycin 600 mg*3

干预措施: Antibiotic prophylaxis (Drug)

Antibiotic prophylaxis

Active Comparator

antibiotic prophylaxis as following: 24 hours coverage with Ampicillin 2 grams*4, Gentamycin 240 mg*1, Clindamycin 600 mg*3

干预措施: Ampicillin (Drug)

Antibiotic prophylaxis

Active Comparator

antibiotic prophylaxis as following: 24 hours coverage with Ampicillin 2 grams*4, Gentamycin 240 mg*1, Clindamycin 600 mg*3

干预措施: Gentamycin (Drug)

Antibiotic prophylaxis

Active Comparator

antibiotic prophylaxis as following: 24 hours coverage with Ampicillin 2 grams*4, Gentamycin 240 mg*1, Clindamycin 600 mg*3

干预措施: Clindamycin (Drug)

结局指标

主要结局

Endometritis rate

时间窗: 3 years

次要结局

  • Puerperal fever(3 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验